Journal article
Health-related quality of life and treatment of postmenopausal osteoporosis: Results from the HORIZON-PFT
Abstract
Osteoporosis-related fractures are associated with reductions in health-related quality of life (HRQL). We examined the benefits of zoledronic acid (ZOL) on HRQL in patients sustaining vertebral and clinical fractures from HORIZON-Pivotal Fracture Trial using mini-Osteoporosis quality of life Questionnaire (OQLQ). In this multicenter, double-blind, placebo-controlled trial, 1434 patients from a cohort of postmenopausal women with osteoporosis …
Authors
Sambrook PN; Silverman SL; Cauley JA; Recknor C; Olson M; Su G; Boonen S; Black D; Adachi JD; Trial FTHPF
Journal
Bone, Vol. 48, No. 6, pp. 1298–1304
Publisher
Elsevier
Publication Date
6 2011
DOI
10.1016/j.bone.2011.03.719
ISSN
8756-3282